Reuters logo
BRIEF-Sensus Healthcare launches SRT-100 in China for Keloid treatment
November 1, 2017 / 12:21 PM / 22 days ago

BRIEF-Sensus Healthcare launches SRT-100 in China for Keloid treatment

Nov 1 (Reuters) - Sensus Healthcare Inc

* Sensus Healthcare Inc - ‍has launched SRT-100 in China for treatment and prevention of Keloids with Chindex Medical Limited​

* Sensus Healthcare- ‍extension of exclusive distribution deal with Chindex Medical, a JV between Fosun Pharma and Chindex International, through 2020​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below